Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$51.76 - $64.15 $510,612 - $632,839
9,865 Added 136.98%
17,067 $935,000
Q1 2024

May 14, 2024

SELL
$48.6 - $57.12 $27,021 - $31,758
-556 Reduced 7.17%
7,202 $402,000
Q4 2023

Feb 12, 2024

BUY
$43.45 - $53.66 $68,781 - $84,943
1,583 Added 25.64%
7,758 $401,000
Q3 2023

Nov 13, 2023

BUY
$50.12 - $58.87 $309,491 - $363,522
6,175 New
6,175 $326,000
Q2 2022

Aug 10, 2022

SELL
$57.25 - $86.63 $432,581 - $654,576
-7,556 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$71.02 - $86.99 $536,627 - $657,296
7,556 New
7,556 $618,000
Q4 2021

Feb 10, 2022

SELL
$76.72 - $92.68 $1.17 Million - $1.42 Million
-15,303 Closed
0 $0
Q3 2021

Oct 28, 2021

BUY
$76.02 - $88.62 $160,250 - $186,810
2,108 Added 15.98%
15,303 $1.21 Million
Q2 2021

Aug 10, 2021

BUY
$73.44 - $87.01 $406,637 - $481,774
5,537 Added 72.3%
13,195 $1.11 Million
Q1 2021

Jul 21, 2021

BUY
$62.9 - $82.41 $13,523 - $17,718
215 Added 2.89%
7,658 $565,000
Q4 2020

Feb 12, 2021

SELL
$46.01 - $68.74 $891,627 - $1.33 Million
-19,379 Reduced 72.25%
7,443 $493,000
Q3 2020

Oct 30, 2020

BUY
$41.91 - $57.81 $33,989 - $46,883
811 Added 3.12%
26,822 $1.21 Million
Q2 2020

Aug 05, 2020

BUY
$39.87 - $56.9 $555,070 - $792,161
13,922 Added 115.16%
26,011 $1.25 Million
Q1 2020

May 11, 2020

BUY
$34.22 - $76.49 $413,685 - $924,687
12,089 New
12,089 $547,000
Q4 2018

Feb 05, 2019

SELL
$84.14 - $125.42 $5.47 Million - $8.15 Million
-64,979 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$101.02 - $130.95 $6.56 Million - $8.51 Million
64,979 New
64,979 $0

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.52B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.